Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis

Clinical trial NCT06058546 · RECRUITING

Trial details

NCT number: NCT06058546
Sponsor: Tasly Pharmaceutical Group Co., Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2023-11-23
Primary completion: 2025-10-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.